Daniel Ansari
46 – 60 of 118
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Pancreatic cancer : Disease dynamics, tumor biology and the role of the microenvironment
(
- Contribution to journal › Scientific review
-
Mark
Thymidylate synthase : A predictive biomarker in resected colorectal liver metastases receiving 5-FU treatment
(
- Contribution to journal › Article
-
Mark
Intratumoural leukocyte infiltration is a prognostic indicator among pancreatic cancer patients with type 2 diabetes
(
- Contribution to journal › Article
-
Mark
Primary lymph node ratio and hepatic resection for colorectal metastases
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Immunohistochemical investigation of prognostic biomarkers in resected colorectal liver metastases : A systematic review and meta-analysis
(
- Contribution to journal › Scientific review
-
Mark
High-density and targeted glycoproteomic profiling of serum proteins in pancreatic cancer and intraductal papillary mucinous neoplasm
(
- Contribution to journal › Article
- 2017
-
Mark
Hemorrhage after Major Pancreatic Resection: Incidence, Risk Factors, Management, and Outcome.
(
- Contribution to journal › Article
-
Mark
Impact of body constitution on complications following pancreaticoduodenectomy : A retrospective cohort study
(
- Contribution to journal › Article
-
Mark
The challenges of centralization with HPB resectional surgery
(
- Contribution to journal › Letter
-
Mark
Does next-generation sequencing of cyst fluid improve management of pancreatic cystic neoplasms?
(
- Contribution to journal › Scientific review
-
Mark
Outcome and evaluation of prognostic factors after pancreaticoduodenectomy for distal cholangiocarcinoma
(
- Contribution to journal › Article
-
Mark
The role of irreversible electroporation (IRE) for locally advanced pancreatic cancer : a systematic review of safety and efficacy
(
- Contribution to journal › Scientific review
-
Mark
Pancreatic ductal adenocarcinoma : Is a cure possible?
(
- Contribution to journal › Scientific review
-
Mark
Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Development and In Vitro Characterization of a Gemcitabine-loaded MUC4-targeted Immunoliposome Against Pancreatic Ductal Adenocarcinoma
(
- Contribution to journal › Article